Future of Intercept’s NASH drug in doubt after FDA panel rejection

Press/Media

Period	21 May 2023

Media coverage

Title	Future of Intercept’s NASH drug in doubt after FDA panel rejection
Media name/outlet	BioPharma Dive
Country/Territory	United States
Date	21/05/23
URL	ct.moreover.com/?a=50838178477&p=1gw&v=1&x=OyPylaGpqxzw5GgPapfZoA
Persons	Brian Lee, Brian Lee